<code id='7B3DD9E54C'></code><style id='7B3DD9E54C'></style>
    • <acronym id='7B3DD9E54C'></acronym>
      <center id='7B3DD9E54C'><center id='7B3DD9E54C'><tfoot id='7B3DD9E54C'></tfoot></center><abbr id='7B3DD9E54C'><dir id='7B3DD9E54C'><tfoot id='7B3DD9E54C'></tfoot><noframes id='7B3DD9E54C'>

    • <optgroup id='7B3DD9E54C'><strike id='7B3DD9E54C'><sup id='7B3DD9E54C'></sup></strike><code id='7B3DD9E54C'></code></optgroup>
        1. <b id='7B3DD9E54C'><label id='7B3DD9E54C'><select id='7B3DD9E54C'><dt id='7B3DD9E54C'><span id='7B3DD9E54C'></span></dt></select></label></b><u id='7B3DD9E54C'></u>
          <i id='7B3DD9E54C'><strike id='7B3DD9E54C'><tt id='7B3DD9E54C'><pre id='7B3DD9E54C'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:6542

          AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

          AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

          advertisement

          The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          'Insanity': 4th of July mass shootings across US kill 13, injure more than 80
          'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

          2:21Policeisonthesceneofamassshootingincidentat800blockofGretnaCourtintheSouthernDistrict,inBaltimor

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          3 hurdles to bringing medical devices to the U.S. market

          Medicaldeviceshavehistoricallybeenseenashavingfasterpathstomarketthantheirpharmacologicalcounterpart